Jan 17, 2022

News provided by Share this article Share this article This report forecasts the market size out to 2025. The report includes detailed breakouts for 14 countries and 5 regions. Is genomic cancer testing bouncing back? What has happened to Direct to Consumer testing? Will all newborns receive Whole Genomic Sequencing at birth? The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower pricing is driving the Genetic Testing industry to record growth. New drugs may only work for people with a certain genetic makeup, and this too is driving the Genetic Testing Industry. The traditional genetic testing market is growing in volume and growing in the breadth of tests creating new life, and new problems for the industry. Predictive Diagnostics? Pharmacogenomic Testing? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years. Genetic Testing Recent Developments Natera Launches Tumor Genomic Profiling Assay 23andMe To Go Public Ancestry Quits Health Offering Aetna Coverage for NIPT to Include All Pregnancies Agios Pharmaceuticals, PerkinElmer Partner on Hereditary Anemia Genetic Testing Tumor, Germline Testing of Cancer Patients Can Give Discordant Results Invitae Completes Acquisition of ArcherDx Prenetics Receives $15M Investment Preconception Carrier Screening Trial Begins in Australia Genetic Testing Clinical Use Just Beginning Fulgent Genetics Q1 Revenues Jump 44 Percent Blueprint Genetics, NICER Consortium Developing Genetic Test for Immunologic, Hematologic Disorders Natera Terminates Qiagen Agreement for Developing NGS-Based Genetic Tests Invitae Acquires Three Companies: YouScript, Genelex, Diploid PerkinElmer SCID Test Chosen for Newborn Screening Evaluation in England Germline Cancer Risk Mutations Sometimes Reported in Tumor Testing Blueprint Genetics, Archimedlife to Launch Genetic Testing in North America Invitae to Offer No-Charge Genetic Testing to Pancreatic Cancer Patients Phosphorus Offers DNA Testing to Assess Disease Risk Arivale Shuts Down Personalized Wellness Business ArcherDX Acquires Baby Genes